122 related articles for article (PubMed ID: 8955621)
1. Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations.
Thewes M; Pohlmann G; Atkinson M; Mueller J; Pütz B; Höfler H
Diagn Mol Pathol; 1996 Dec; 5(4):284-90. PubMed ID: 8955621
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of stromelysin-3 in basal cell carcinomas.
Majmudar G; Nelson BR; Jensen TC; Voorhees JJ; Johnson TM
Mol Carcinog; 1994 Jan; 9(1):17-23. PubMed ID: 8297480
[TBL] [Abstract][Full Text] [Related]
3. Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance.
Yang W; Arii S; Gorrin-Rivas MJ; Mori A; Onodera H; Imamura M
Cancer; 2001 Apr; 91(7):1277-83. PubMed ID: 11283927
[TBL] [Abstract][Full Text] [Related]
4. Amplification of stromelysin-3 transcripts from carcinomas of the colon.
Johnson LD; Hunt DM; Kim K; Nachtigal M
Hum Pathol; 1996 Sep; 27(9):964-8. PubMed ID: 8816893
[TBL] [Abstract][Full Text] [Related]
5. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes.
Porte H; Chastre E; Prevot S; Nordlinger B; Empereur S; Basset P; Chambon P; Gespach C
Int J Cancer; 1995 Feb; 64(1):70-5. PubMed ID: 7665251
[TBL] [Abstract][Full Text] [Related]
6. Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Hähnel E; Harvey JM; Joyce R; Robbins PD; Sterrett GF; Hähnel R
Int J Cancer; 1993 Nov; 55(5):771-4. PubMed ID: 8244574
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
McDonnell S; Navre M; Coffey RJ; Matrisian LM
Mol Carcinog; 1991; 4(6):527-33. PubMed ID: 1793490
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Mori M; Barnard GF; Mimori K; Ueo H; Akiyoshi T; Sugimachi K
Cancer; 1995 Mar; 75(6 Suppl):1516-9. PubMed ID: 7889484
[TBL] [Abstract][Full Text] [Related]
9. Stromelysin-3 expression in noninvasive and invasive neoplasms of the urinary bladder.
Mueller J; Steiner C; Höfler H
Hum Pathol; 2000 Jul; 31(7):860-5. PubMed ID: 10923925
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Newell KJ; Witty JP; Rodgers WH; Matrisian LM
Mol Carcinog; 1994 Aug; 10(4):199-206. PubMed ID: 8068180
[TBL] [Abstract][Full Text] [Related]
11. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
[TBL] [Abstract][Full Text] [Related]
12. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression.
Wright JH; McDonnell S; Portella G; Bowden GT; Balmain A; Matrisian LM
Mol Carcinog; 1994 Aug; 10(4):207-15. PubMed ID: 8068181
[TBL] [Abstract][Full Text] [Related]
13. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
14. Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
Polette M; Clavel C; Birembaut P; De Clerck YA
Pathol Res Pract; 1993 Nov; 189(9):1052-7. PubMed ID: 8302724
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
Maurer CA; Graber HU; Friess H; Beyermann B; Willi D; Netzer P; Zimmermann A; Büchler MW
Surgery; 1999 Nov; 126(5):869-80. PubMed ID: 10568187
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of stromelysin-3 and insulin-like growth factor II in tumors of ectodermal, mesodermal, and endodermal origin: indicator of a fetal cell phenotype.
Singer CF; Rasmussen A; Lippman ME; Cullen KJ
J Clin Endocrinol Metab; 1997 Jun; 82(6):1917-22. PubMed ID: 9177406
[TBL] [Abstract][Full Text] [Related]
17. Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential.
Mueller J; Brebeck B; Schmalfeldt B; Kuhn W; Graeff H; Höfler H
Virchows Arch; 2000 Dec; 437(6):618-24. PubMed ID: 11193473
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
[TBL] [Abstract][Full Text] [Related]
19. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum.
Mueller J; Mueller E; Arras E; Bethke B; Stolte M; Höfler H
Virchows Arch; 1997 Mar; 430(3):213-9. PubMed ID: 9099978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
